PCAS S.A. | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,431.00
2,364.00
8,780.00
6,831.00
6,153.00
358
Depreciation, Depletion & Amortization
8,421.00
9,657.00
9,757.00
9,948.00
10,518.00
12,131
Other Funds
-
-
1,637.00
1,649.00
839.00
4,088
Funds from Operations
12,741.00
12,029.00
21,025.00
18,951.00
17,815.00
15,316
Changes in Working Capital
1,229.00
3,119.00
8,679.00
17,282.00
7,989.00
12,777
Net Operating Cash Flow
13,970.00
8,910.00
29,704.00
1,669.00
9,826.00
28,093
Capital Expenditures
11,802.00
9,795.00
15,699.00
17,204.00
16,479.00
Sale of Fixed Assets & Businesses
106.00
112.00
62.00
1,512.00
109.00
Purchase/Sale of Investments
-
33.00
7.00
-
7.00
Net Investing Cash Flow
11,334.00
9,719.00
15,646.00
15,692.00
16,377.00
Issuance/Reduction of Debt, Net
873.00
15,210.00
836.00
8,387.00
2,096.00
Net Financing Cash Flow
2,335.00
15,210.00
775.00
8,239.00
1,257.00
Net Change in Cash
4,944.00
14,447.00
13,287.00
5,765.00
5,328.00
Free Cash Flow
2,987.00
500.00
14,508.00
15,251.00
4,409.00
Deferred Taxes & Investment Tax Credit
-
-
-
1,866.00
602.00
545
Other Sources
362.00
-
-
-
-
Change in Capital Stock
3,208.00
-
1,698.00
1,501.00
-
Exchange Rate Effect
27.00
46.00
4.00
19.00
34.00
Other Uses
-
3.00
2.00
-
-

About PCAS

View Profile
Address
23, rue Bossuet
Longjumeau Ile-de-France 91160
France
Employees -
Website http://www.pcas.com
Updated 07/08/2019
Produits Chimiques Auxiliaires et de Synthèse SA engages in developing, manufacturing and selling of chemicals. It operates through the Pharmaceutical Synthesis and Fine Chemical sectors. The Pharmaceutical Synthesis sector manufactures active ingredients, generics, and biomaterials.